학술논문

An exposure-response analysis of ponesimod clinical efficacy in a randomized phase III study in patients with relapsing multiple sclerosis
Document Type
Article
Source
In: CPT: Pharmacometrics and Systems Pharmacology. (CPT: Pharmacometrics and Systems Pharmacology, October 2022, 11(10):1294-1304)
Subject
Language
English
ISSN
21638306